Free Offer
Open Demat FREE
Apply in Accretion Pharmaceuticals Ltd IPO via ASBA / UPI
₹0 Opening Digital KYC 1-Click Apply
SEBI Regulated · 100% Secure · Under 5 Min
Home All IPOs Accretion Pharmaceuticals Ltd IPO
Accretion Pharmaceuticals Ltd IPO
NSE SME Bookbuilding IPO Fresh Capital Closed Live Chart
GMP +₹0 +0% Est. Listing ₹101
Issue Price
₹101
Face ₹10
GMP
+₹0
+0% premium
Est. Listing
₹101
GMP based
Lot Size
1,200
shares / lot
Min Amount
₹121,200
1 lot · 1,200 shares
Live Price
tap to chart
Allotment
Important Dates
6/6 completed
Open
Close
Allotment
Refund
Demat
Listing
Done
Open Date
14 May 2025
Wed Completed
Done
Close Date
16 May 2025
Fri Completed
Done
Allotment
19 May 2025
Mon Completed
Done
Refund
20 May 2025
Tue Completed
Done
Demat Credit
19 May 2025
Mon Completed
Done
Listing Date
21 May 2025
Wed Completed
Issue Details
Pricing & Size
Issue Price
₹101 Face ₹10
Lot Size
1,200 shares
Min Investment
₹121,200
Total Issue Size
29,46,000 shares (aggregating up to ₹29.75 Cr)
IPO Information
Issue Type
Bookbuilding IPO
Sale Type
Fresh Capital
Listing Exchange
NSE SME
Script / Ticker
-
Allocation Breakdown
Market Maker
1,47,600 (5.01%)
QIB Portion
3,52,800 (11.98%)
NII / HNI
12,22,800 (41.51%)
Retail
12,22,800 (41.51%
Employee
-
Net Offer to Public
27,98,400 shares (aggregating up to ₹28.26 Cr)
Shareholding Pattern
Pre-Issue Shareholding
81,70,000 shares
Post-Issue Shareholding
1,11,16,000 shares
Application Size
CategoryMin LotsSharesAmount
Retail (sNII) 1 1200 ₹1,21,200
HNI / NII 2 2,400 ₹2,42,400
Objects of Issue
5 objectives
1
Capital expenditure towards purchase of new equipment/ machineries, etc.
2.70 Cr
2
Capital expenditure towards upgradation of existing manufacturing facility
4.66 Cr
3
Repayment/prepayme nt of certain borrowings availed by the Company
0.99 Cr
4
Funding working capital requirements
14.68 Cr
5
General Corporate Purpose
4.43 Cr
Lead Managers & Market Maker
Book Running Lead Managers
Jawa Capital Services Pvt.Ltd
Market Maker
Gretex Share Broking Pvt.Ltd
IPO Timeline
Open
14 May
✓ Done
Close
16 May
✓ Done
Allotment
19 May
✓ Done
Listing
21 May
✓ Done
Registrar Details
Kfin Technologies Ltd
SEBI Registered Registrar & Transfer Agent
Phone
04067162222, 04079611000
Email
apl.ipo@kfintech.com
Company Contact
Email
compliance@accretionpharma.com
Phone
+91-97148 82929
Address
29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand, Ahmedabad, Gujarat, 382213
Grey Market Premium
LIVE
Current GMP
+₹0
+0% vs Issue Price
Issue Price
₹101
Est. Listing
₹101
Lot Size
1,200 shares
P&L / Lot
+₹0
GMP is unofficial grey market data. Does not guarantee listing price or returns.
GMP Return Calculator
Estimated Listing
GMP %
Investment (1 Lot)
Total Investment
Expected P&L
ROI
Accretion Pharmaceuticals Ltd LIVE
INR ·
vs Issue
Open
High
Low
Mkt Cap
P/E
52W H
52W L
Vol
Div
Yld
Loading chart…
Live Chart Not Available
Accretion Pharmaceuticals Ltd is not yet listed or data is unavailable.
Chart will appear after listing
| Price
Market Reference
IPO Issue Price
₹101
GMP
+₹0 (+0%)
GMP Est. Listing
₹101
Previous Close
Exchange
Data from Yahoo Finance. May be delayed 15–20 min. GMP is unofficial. Not investment advice.
Category-wise Subscription
Category Sub (×) Offered Bid For Amt (Cr)*
QIB 3,52,800 (11.98%) ₹356.33 Cr
NII / HNI (Total) 12,22,800 (41.51%) ₹1,235.03 Cr
Retail Investors 12,22,800 (41.51% ₹1,235.03 Cr
Total ** 29,46,000 (100.00%) ₹29,754.60 Cr
Market Maker * 1,47,600 (5.01%) ₹14.91 Cr
* Based on ₹101.00 (upper price band)
NII / HNI Breakdown
Shares Reserved
QIB
3,52,800 (11.98%)
NII
12,22,800 (41.51%)
Retail
12,22,800 (41.51%
Market Maker
1,47,600 (5.01%)
* Shares Offered and Total Amount are indicative. ** Excluding Market Maker portion. Data sourced from exchange bidding platform.
Financial Summary
Amount in ₹ Crore
Metric31 Dec 202431 Mar 202431 Mar 2023
Revenue35.7533.9429.53
PAT5.243.880.10
EBITDA
Net Worth13.585.353.84
Total Assets39.9927.0520.58
Reserves5.411.350.00
Borrowings13.7913.488.47
Key Financial Ratios
72.47%
ROE
Return on Equity
36.73%
ROCE
Return on Capital Employed
72.47%
RONW
Return on Net Worth
11.51%
PAT Margin
PAT / Revenue
2.52
D/E Ratio
Debt to Equity
7.55
P/BV
Price to Book Value
4.74
Pre EPS
EPS Pre-Issue
6.28
Post EPS
EPS Post-Issue
21.29
Pre P/E
P/E Pre-Issue
16.08
Post P/E
P/E Post-Issue
About Accretion Pharmaceuticals Ltd

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.

The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).

The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems.

The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat.

The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.

Product Portfolio and Services

  • Tablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.
  • Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments.
  • External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.
  • Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health.

As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.

Competitive Strength:

  • Experienced Promoters and Management Team.
  • Long-standing relationship with clients and suppliers.
  • Focus on providing quality products.
  • Management has built a supply chain and customer relations, creating goodwill and trust.
Frequently Asked Questions
What is the issue price of Accretion Pharmaceuticals Ltd IPO?
The issue price of Accretion Pharmaceuticals Ltd IPO is ₹101 per share, face value ₹10.
What is the lot size?
Minimum lot size is 1,200 shares, requiring ₹121,200.
What are the IPO dates?
Opens 14 May 2025, closes 16 May 2025.
When is the listing date?
Tentative listing: 21 May 2025 on NSE SME.
What is the current GMP?
Current GMP is +₹0, estimated listing ₹101 (+0%). GMP is unofficial.
How to apply?
Apply via ASBA through your bank, or via UPI through any broker app.

Check Allotment Status

Accretion Pharmaceuticals Ltd IPO · Expected 19 May 2025

Check on Registrar
Post-IPO Timeline
Allotment Date
19 May 2025
Refund Initiation
20 May 2025
Demat Credit
19 May 2025
Listing Date
21 May 2025
Live Price LIVE
Quick Facts
Closed
GMP Signal
Bullish
+₹0
+0%
Issue Price
₹101
Face ₹10
Lot Size
1,200
shares / lot
Min Amount
₹121,200
1 lot
Est. Listing
₹101
GMP +₹0
Key Dates
Open
14 May Done
Close
16 May Done
Listing
21 May Done
Registrar
Kfin Technologies Ltd
A
Sponsored
₹0 AMC · Apply IPOs via UPI
SEBI Regulated · Digital KYC in 5 min